BNGOW

Bionano Genomics Inc.

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

BNGOW price

Bionano Genomics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment BNGOW

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals BNGOW

Valuation

P/E

0.00

Sector 0.84

Industry -1.42

P/BV

0.00

Sector 1.82

Industry 1.25

P/Revenue (PSR)

Sector 1.48

Industry 2.13

EV/EBITDA

Sector -43.66

Industry -35.45

EV/EBIT

Sector -47.57

Industry -38.86

P/EBITDA

Sector -31.25

Industry -21.12

P/EBIT

Sector -42.58

Industry -25.59

P/Total Assets

Sector 0.82

Industry 0.70

P/Net Current Assets

0.00

Sector -23.77

Industry -59.56

P/Working Capital

0.00

Sector -3.73

Industry -1.93

EPS

-2.79

Sector -0.70

Industry -1.22

BVPS

2.74

Sector 4.50

Industry 2.78

Efficiency

Gross Margin

47.51%

Sector 49.32%

Industry 49.70%

EBITDA Margin

-57.64%

Sector -305.63%

Industry -17,123,193.33%

EBIT Margin

-100.00%

Sector -19.73%

Industry -25.36%

Net Profit Margins

-100.00%

Sector -23.90%

Industry -27.40%

Asset Turnover

0.17

Sector 0.13

Industry 0.06

Profitability

ROE

-101.76%

Sector -24.30%

Industry -38.97%

ROA

-67.58%

Sector -24.50%

Industry -49.14%

ROIC

-75.14%

Sector -584.46%

Industry -1,072.15%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.48

Sector 1.92

Industry 2.55

Net Debt / EBITDA

Sector -23.10

Industry -8.80

Net Debt / EBIT

Sector -17.84

Industry -36.75

Net Debt / Equity

Sector -0.68

Industry -1.16

Gross Debt / Equity

Sector -0.72

Industry -0.54

Equity/Assets

0.66

Sector 0.46

Industry 0.52

Liabilities/Assets

0.34

Sector 0.50

Industry 0.47

Growth

5Y Revenue CAGR

10.91%

Sector -

Industry -

5Y Earnings CAGR

-14.99%

Sector -

Industry -

Fundamentals BNGOW

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BNGOW Bionano Genomics Inc.	$0.00	-	0.00%	0.00	0.00	-101.76%	-100.00%
TMO Thermo Fisher Scientific Inc.	$673.79	25.46%	0.27%	36.53	4.83	13.22%	15.04%
DHR Danaher Corporation	$224.14	8.20%	0.63%	40.42	3.08	7.61%	15.95%
IQV IQVIA Holdings Inc.	$264.46	29.29%	0.00%	32.26	7.04	21.82%	8.10%
WAT Waters Corporation	$433.59	29.59%	0.00%	257.58	2.82	1.09%	3.58%
SHC Sotera Health Company	$17.85	10.46%	0.00%	31.30	7.69	24.56%	13.44%
CGEN Compugen Ltd.	$1.98	5.33%	0.00%	6.91	2.14	31.01%	36.12%
SYNH Syneos Health Inc.	$0.00	-	0.00%	62.97	1.28	2.04%	1.31%
JNJ Johnson & Johnson	$252.71	34.46%	2.08%	29.04	7.19	24.76%	21.48%
LLY Eli Lilly and Compay	$1,249.76	56.65%	0.53%	42.13	33.21	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$431.59	-3.26%	0.00%	48.53	8.32	17.15%	28.44%
SNY Sanofi	$39.81	-18.25%	4.38%	3.78	0.70	18.43%	14.25%
NVS Novartis AG	$150.19	16.49%	2.05%	22.56	6.86	30.41%	23.29%
ABT Abbott Laboratories	$103.75	-16.91%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$92.84	0.14%	3.02%	23.20	2.39	10.29%	13.93%
GSK GlaxoSmithKline PLC	$49.36	16.30%	3.58%	15.38	4.34	28.24%	14.54%
CVS CVS Health Corporation	$91.15	14.82%	2.89%	24.09	1.47	6.12%	1.18%
BSX Boston Scientific Corp.	$44.56	-55.10%	0.00%	17.83	2.63	14.73%	17.49%
TMDX TransMedics Group Inc.	$72.35	-38.50%	0.00%	16.36	4.79	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$556.87	-12.36%	0.00%	38.87	27.47	70.67%	25.03%
RMD ResMed Inc.	$239.43	-9.75%	1.03%	22.76	5.27	23.13%	26.94%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BNGOW - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Bionano Genomics

Bionano Genomics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

19 years

Founded: 2007

2018

Time since IPO - 8 years

147

Employees

Bionano Genomics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $31.61 million.

The company employs approximately 147 people and operates in the Health sector, within the Life Science Tools and Services industry.

Over the past 12 months, Bionano Genomics Inc. reported $30.18 million in revenue, generating net income of $-32.16 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BNGOW.

Market cap

Net worth

$31.61 million

$31,606,000.00

Assets

$47.59 million

$47,591,000.00

Total Shares Outstanding

11.55 million

11,546,000

Average Daily Trading Volume

$33.66 Thousand

$33,661.30

Sector

Health

Industry

Life Science Tools and Services

BNGOW

BNGOW revenue and profits

Financial Results BNGOW

DRAG THE FRAME TO SEE MORE DATA

BNGOW cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$91.15 14,82% (12M)

P/E

24.09

2.89%

ROE

6.12%

P/BV

1.47

CI - Cigna

$296.71 1,38% (12M)

P/E

11.63

2.05%

ROE

16.04%

P/BV

1.87

CNC - Centene

$68.16 93,24% (12M)

P/E

-6.73

0.00%

ROE

-22.53%

P/BV

1.52

HUM - Humana

$411.55 52,12% (12M)

P/E

39.10

0.85%

ROE

6.63%

P/BV

2.59

SNY - Sanofi

$39.81 --18,25% (12M)

P/E

3.78

4.38%

ROE

18.43%

P/BV

0.70

JNJ - Johnson & Johnson

$252.71 34,46% (12M)

P/E

29.04

2.08%

ROE

24.76%

P/BV

7.19

LLY - Eli Lilly

$1,249.76 56,65% (12M)

P/E

42.13

0.53%

ROE

78.84%

P/BV

33.21

HCA - HCA Healthcare

$454.64 7,19% (12M)

P/E

14.90

0.66%

ROE

-213.15%

P/BV

-31.76